Extend Your Options

Extend your Options Logo

The Radial Access Alternative

CSI is leading the way in providing innovative solutions that enable a streamlined approach for your patients from treatment to discharge by providing you with the only extended length atherectomy system designed to treat peripheral artery disease (PAD) through radial access.

Watch How You Can Extend Your Options

Proven Technology

REACH PVI is a prospective, observational, single-arm study designed to evaluate acute clinical outcomes of orbital atherectomy (OA) via transradial access for treatment of PAD in lower extremity lesions. A total of 50 patients were enrolled across six US centers.

It is the first multi-center study to evaluate outcomes of OA utilizing transradial artery access.

Utilizing orbital atherectomy in radial peripheral vascular interventions (PVIs) was shown to have a high rate of procedural and treatment success, delivering confidence with our proven orbital atherectomy technology, while providing you an alternative access site option to treat your patients.

Watch Dr. Ankur Lodha Present the Full Reach PVI Study Results

Study Takeaways1

High Rate Of Success


Rate of Treatment Success*


Rate of Procedural Success**

Low Complication Rates


Rate of Serious Angiographic Complications


Rate of Transradial Access Site Bleeding/Hematoma

*Final residual stenosis <50% without stent placement or <30% residual stenosis with stent placement and without significant angiographic complications.
**Successful completion of OA treatment of target lesion via transradial access without serious transradial access related events.

Effective in Reducing Residual Stenosis Across All Lesions


Short Recovery Time for Improved Patient Satisfaction and Staff Efficiency

2.7 hours
7.2 hours

Optimize the Patient Experience


CSI’s peripheral orbital atherectomy system is the only atherectomy device that enables you to use radial access in peripheral interventions giving you another option when facing dynamic procedural challenges by providing an alternative access site for challenging anatomies, enabling immediate ambulation post-procedure2, and faster discharge times which can improve the patient experience. These benefits help to address the daily challenges you and your team experience while providing increased patient satisfaction.3

  • Decreases time to hemostasis4
  • Provides immediate ambulation post-procedure2
  • Shortens (hospital) stay5
  • Minimizes access site bleeding complications2
  • Avoids diseased common femoral arteries6
  • Allows treatment of bilateral disease in one procedure6
  • Eliminates need for femoral closure devices2
  • Improves patient experience2, 3

Watch Dr. Christopher Stout, MD, Mercy Hospital Springfield, MO, walk through a patient procedure utilizing radial access.

Radial Access Case Studies

Extended Length Portfolio

Treating lower extremity PAD radially requires a unique combination of extended-length and low-profile devices.

Peripheral Orbital Atherectomy System

Extended lengths designed to maintain pushability and control while treating PAD patients through the radial artery.

  • 180 cm and 200 cm working catheter lengths
  • 5 Fr profile on all extended-length devices
  • Delivers additional pushability with increased filar count
  • 017” tapered crossing profile

Cardiovascular Systems Inc (CSI) Flextip

Vipercath XC Peripheral Exchange Catheter

The longest length exchange catheter available to guide and support guide wire access in the vasculature and allow for wire exchanges while providing a conduit for delivering saline and contrast.

  • Designed for kink resistance, torquability and support during delivery.
  • Facilitates advancement of a 0.035“ guide wire and CSI’s Peripheral ViperWire Advance®.
  • 5 Fr crossing profile
  • Straight and angled tip options to aid in wire positioning

Viperwire® Advance Guide Wires

Available in longer lengths to treat PAD patients.

  • 475 cm extended length
  • Available in 0.014”/0.014” and 0.014”/0.018” tip options

Patient Experience with Orbital Atherectomy and Radial Access

Stay In Touch.

Join our email list to get updates about our commitment to constant progress.  You’ll see how CSI  and orbital first users are shaping the future of PVIs.

You can unsubscribe from these communications at any time. Please review our Privacy Policy and Terms of Use for more information.

If you believe someone may be unintentionally or intentionally violating the law or the principles or standards, report the known or suspected violations by visiting our compliance page.

CSI is a registered trademark of Cardiovascular Systems, Inc. ©2023 All Rights Reserved.

1 Lodha A. REACH PVI Clinical Study Results. Presented at NCVH 2020.
2 Sanghvi K, Coppola J. Intervent Cardiol Clin. 2015;4(2):179–192.
3 Thakor A, et al. Can Assoc Radiol J. 2017;68(3):318-327.
4 Santas E, et al. Rev Esp Cardiol. 2009;62(5):482-490.
5 Amin A, et al. JACC Cardiovasc Interv. 2013;6(8):827-384.
6 Coscas R, et al. J Vasc Surg. 2015;61(2):463-468.